Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

Vaccine businesses seen as valuable parts of pharma groups but government hostility could deter future developments ...

A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of ...

Robert Malone, who believes the U.S. government has “reality-bending information-control capabilities,” will guide the future ...

(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

BioNTech won a major shot in the arm for its cancer drug activities last week when Bristol Myers Squibb agreed to pay up to ...

Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in ...